Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Sacubitril/Valsartan 97/103 mg Film-coated Tablets in Healthy Thai Volunteers
TCTR20240819001Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of sacubitril + valsartan in heart failure (HF) (2 arms), sponsored by International Bio Service. Primary endpoint: Primary pharmacokinetic bioequivalence parameters. Status: unknown.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on TCTR20240819001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240819001.